Coastal Investment Advisors, Inc. Crispr Therapeutics Ag Transaction History

Coastal Investment Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 23, 2020	SELL	$33.68 - $62.53 $20,679 - $38,393	-614 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$36.68 - $73.13 $917 - $1,828	-25 Reduced 3.91%	614 $44,000
Q3 2019 Oct 18, 2019	BUY	$40.99 - $52.56 $26,192 - $33,585	639 New	639 $26,000
Q2 2019 Aug 01, 2019	SELL	$35.45 - $48.2 $36,690 - $49,887	-1,035 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$28.02 - $40.87 $29,000 - $42,300	1,035 New	1,035 $38,000

499

56.8M

1.7M

1.8M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.05B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.